Red blood cell transfusion practices: comparison with the American Multicenter Trial of EPO in Infants < 1251 g22
| Ulm No EPO | EPO trial | ||||
|---|---|---|---|---|---|
| 500 IU EPO /week | No EPO | ||||
| Number | 140 | 77 | 80 | ||
| Mean birth weight (g) | 907 | 923 | 925 | ||
| ⩽750 g | 35 (25) | 13 (17) | 17 (21) | ||
| 751–1000 g | 54 (39) | 39 (51) | 31 (39) | ||
| 1001–1250 g | 51 (36) | 25 (32) | 32 (40) | ||
| Mean gestational age (weeks) | 27.0 | 26.8 | 27.1 | ||
| Not transfused4-150 | 72 (51) | 33 (43) | 25 (31) | ||
| Mean RBCT/infant4-150 | 0.964 | 1.1 | 1.6 | ||
| Mean volume transfused4-150(ml/infant) | 13.5 | 16.5 | 23.9 | ||
Where appropriate, values are number (%).
↵4-150 During the observation period—that is, for 42 days after study entry in the Shannon trial and for days 7–64 at the Ulm centre.
EPO, Erythropoietin; RBCT, red blood cell transfusion.